Travere Therapeutics Inc. buy klostergang
Start price
01.07.19
/
50%
€19.10
Target price
04.11.21
€33.37
Performance (%)
-35.06%
End price
17.06.21
€12.40
Summary
This prediction ended on 17.06.21 with a price of €12.40. The BUY prediction by klostergang for Travere Therapeutics Inc. performed very badly with a performance of -35.06%. klostergang has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Travere Therapeutics Inc. | 27.007% | 27.007% | 171.875% | - |
| iShares Core DAX® | 0,44 % | 3,03 % | 12,68 % | 49,79 % |
| iShares Nasdaq 100 | 3,82 % | 4,07 % | 33,15 % | 88,25 % |
| iShares Nikkei 225® | 1,15 % | 6,90 % | 45,49 % | 61,92 % |
| iShares S&P 500 | 2,37 % | 2,68 % | 25,69 % | 63,54 % |
Comments by klostergang for this prediction
In the thread Travere Therapeutics Inc. diskutieren
Retrophin mit FDA-Zulassung zur Behandlung von Cystinurie und
fortgeschrittener pipeline: